The popularity of Viagra initially sparked a surge for the drug industry, however recent shifts present a complicated scenario for shareholders. Off-patent competitors are reducing earnings, and continued litigation https://janeesnz616361.qowap.com/100219072/sildenafil-and-pharma-a-volatile-investment